163 related articles for article (PubMed ID: 38421976)
1. Changes in nonalcoholic fatty liver disease and M2BPGi due to lifestyle intervention in primary healthcare.
Nah EH; Choi YJ; Cho S; Park H; Kim S; Kwon E; Cho HI
PLoS One; 2024; 19(2):e0298151. PubMed ID: 38421976
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
[TBL] [Abstract][Full Text] [Related]
3. Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
Zhang HJ; He J; Pan LL; Ma ZM; Han CK; Chen CS; Chen Z; Han HW; Chen S; Sun Q; Zhang JF; Li ZB; Yang SY; Li XJ; Li XY
JAMA Intern Med; 2016 Aug; 176(8):1074-82. PubMed ID: 27379904
[TBL] [Abstract][Full Text] [Related]
4. Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial.
Dong F; Zhang Y; Huang Y; Wang Y; Zhang G; Hu X; Wang J; Chen J; Bao Z
Sci Rep; 2016 Nov; 6():36783. PubMed ID: 27830836
[TBL] [Abstract][Full Text] [Related]
5. Mobile App-Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
Kwon OY; Lee MK; Lee HW; Kim H; Lee JS; Jang Y
J Med Internet Res; 2024 Feb; 26():e49839. PubMed ID: 38358794
[TBL] [Abstract][Full Text] [Related]
6. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.
Wong VW; Chan RS; Wong GL; Cheung BH; Chu WC; Yeung DK; Chim AM; Lai JW; Li LS; Sea MM; Chan FK; Sung JJ; Woo J; Chan HL
J Hepatol; 2013 Sep; 59(3):536-42. PubMed ID: 23623998
[TBL] [Abstract][Full Text] [Related]
7. [Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial].
Dong C; Zhang CR; Xue BY; Miu WF; Fang NY; Li K; Ou ZJ; Xu YQ
Zhongguo Zhen Jiu; 2020 Feb; 40(2):129-34. PubMed ID: 32100496
[TBL] [Abstract][Full Text] [Related]
8. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
[TBL] [Abstract][Full Text] [Related]
9. An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.
Mazzotti A; Caletti MT; Brodosi L; Di Domizio S; Forchielli ML; Petta S; Bugianesi E; Bianchi G; Marchesini G
J Hepatol; 2018 Nov; 69(5):1155-1163. PubMed ID: 30290973
[TBL] [Abstract][Full Text] [Related]
10. Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
Lim SL; Johal J; Ong KW; Han CY; Chan YH; Lee YM; Loo WM
JMIR Mhealth Uhealth; 2020 Apr; 8(4):e14802. PubMed ID: 32281943
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of lifestyle interventions in the reversion to normoglycemia in Korean prediabetics: One-year results from a randomised controlled trial.
Nah EH; Chu J; Kim S; Cho S; Kwon E
Prim Care Diabetes; 2019 Jun; 13(3):212-220. PubMed ID: 30583933
[TBL] [Abstract][Full Text] [Related]
12. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.
Zelber-Sagi S; Bord S; Dror-Lavi G; Smith ML; Towne SD; Buch A; Webb M; Yeshua H; Nimer A; Shibolet O
World J Gastroenterol; 2017 Mar; 23(10):1881-1890. PubMed ID: 28348495
[TBL] [Abstract][Full Text] [Related]
13. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease.
Pacifico L; Arca M; Anania C; Cantisani V; Di Martino M; Chiesa C
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1010-6. PubMed ID: 23018041
[TBL] [Abstract][Full Text] [Related]
14. Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study.
Pfirrmann D; Huber Y; Schattenberg JM; Simon P
J Med Internet Res; 2019 Jan; 21(1):e11250. PubMed ID: 30602434
[TBL] [Abstract][Full Text] [Related]
15. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
[TBL] [Abstract][Full Text] [Related]
16. Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping.
Hallsworth K; McPherson S; Anstee QM; Flynn D; Haigh L; Avery L
J Med Internet Res; 2021 Jan; 23(1):e20491. PubMed ID: 33448929
[TBL] [Abstract][Full Text] [Related]
17. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
[TBL] [Abstract][Full Text] [Related]
18. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
BMJ Open; 2017 Jul; 7(7):e016914. PubMed ID: 28698350
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases.
Jang SY; Tak WY; Park SY; Kweon YO; Lee YR; Kim G; Hur K; Han MH; Lee WK
Ann Lab Med; 2021 May; 41(3):302-309. PubMed ID: 33303715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
